Anti-influenza-virus broad-spectrum-neutrality neutralizing molecule 3E1

A technology combining molecules and influenza viruses, applied in the direction of antiviral agents, antiviral immunoglobulins, antibodies, etc., can solve the problems of restricting the large-scale use of chemical small molecule drugs and not recommending alkylamine drugs, etc., to achieve prevention or treatment Effects of Multiple Influenza Virus Infections

Active Publication Date: 2014-03-26
CENT FOR EXCELLENCE IN MOLECULAR CELL SCI CHINESE ACAD OF SCI
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

A large number of drug-resistant influenza strains have emerged for alkylamine drugs, so the World Health Organization does not recommend the use of alkylamine drugs as a drug for treating influenza; most influenza viruses (including influenza A ...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-influenza-virus broad-spectrum-neutrality neutralizing molecule 3E1
  • Anti-influenza-virus broad-spectrum-neutrality neutralizing molecule 3E1
  • Anti-influenza-virus broad-spectrum-neutrality neutralizing molecule 3E1

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0176] Example 1, HA-specific memory B cells

[0177] Using FITC-CD19 / APC-IgG / Cy3-HA as specific markers, several HA-specific B cells were obtained.

Embodiment 2

[0178] Embodiment 2, antibody gene

[0179] RT-PCR and Nested-PCR method to obtain antibody heavy and light chain variable region genes, the molecular weight is about 400bp, β-actin is used as an internal reference (343bp), and the electrophoretic pattern is shown in figure 2 , image 3 and Figure 4 . The variable regions of heavy and light chain genes derived from the same B cell antibody were connected to T vectors, sequenced and constructed for expression vectors.

[0180] The sequence of the 3E1 heavy chain variable region gene is as follows (SEQ ID NO: 1):

[0181] CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGA AGCCTTCGGAGACCCTGTCCCTCACGTGCAGTGTCTCT TGGATCTGGATCCGGCAGCCCGCCGGGAAGGGACTGGAGTGGATTGGGCGT AACTACAACCCCTCCTCAGGAGTCGAGTCACCATGTCGGTGGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGACCTCTGTGACCGCCGCGGACACGGCCGTGTATTACTGT TGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA

[0182] Remarks: The sequences marked with double underlines are heavy chain gene CDR1 (SEQ ID NO: 5), CDR2 (SEQ ID NO: ...

Embodiment 3

[0192] Embodiment 3, antibody expression

[0193] The results of ELISA showed that the fully human antibody was successfully expressed, and its concentration was 200-300 μg / ml. Because the expression vector already contains the constant region of the heavy and light chain, the 293T cells transfected with the empty vector can also express the constant region of the heavy and light chain of the antibody, see Figure 5 .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an anti-influenza-virus broad-spectrum-neutrality neutralizing molecule 3E1 capable of neutralizing multiple influenza virus subtypes. The functions of the antibody provided by the invention are determined by specific gene sequences of genes in light chain and heavy chain variable regions; and the antibody can be combined with HA2 subunit of influenza virus hemagglutinin (HA) with native conformation, and can prevent multiple influenza virus subtypes from infecting permissive cells. By utilizing the variable region genes or complementary determining region (CDR) genes, different forms of gene engineering antibodies can be modified and produced in any expression system using prokaryotic and eukaryotic cells.

Description

technical field [0001] The invention provides a fully human monoclonal antibody 3E1 capable of neutralizing multiple subtypes of influenza viruses, which has the potential to prevent or treat multiple influenza virus infections clinically. Background technique [0002] Since April 2009, influenza A (H1N1) (A / H1N) outbreaks have broken out worldwide. The epidemic spread rapidly from North America to more than 200 countries and regions on five continents. According to the World Health Organization, as of April 9, 2010, influenza A / H1N1 has broken out in more than 213 countries, and the number of deaths from influenza A / H1N1 worldwide has exceeded 17,700. In my country, according to the Chinese Center for Disease Control and Prevention, as of March 31, 2010, more than 127,000 confirmed cases of Influenza A (H1N1) had been reported in 31 provinces across the country, 122,000 had been cured and 800 had died. [0003] Influenza viruses belong to the Orthomyxoviridae family and h...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K16/10C12N15/13C12N15/63C12N1/15C12N1/19C12N1/21C12N5/10G01N33/577A61K39/42A61P31/16
Inventor 孙兵孙轶卓陈爱中边超胡伟斌王同燕
Owner CENT FOR EXCELLENCE IN MOLECULAR CELL SCI CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap